Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 573
Selected: 0
NCT IDTitle
NCT05188859First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
NCT07166003Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
NCT05524389Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions
NCT03383562Daytime Variation of Complication in Gastric and Pancreatic Surgery
NCT03398941The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial
NCT07656116Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors
NCT06149533Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
NCT0608476768Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer
NCT05944809The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients
NCT05504265Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
NCT07117864Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer
NCT06490081Trilaciclib Prevents Myelosuppression With Chemoradiotherapy
NCT07390565YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer
NCT06824792Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System
NCT02933294Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer
NCT06354036Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy
NCT06711471Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer
NCT06411457SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer
NCT06959732Zanubrutinib Combined With G-CVP in Previously Untreated FL
NCT06958614Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC
NCT05235100Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma (SPARE-02)
NCT06417892Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
NCT03014102Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation
NCT03405272Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC
NCT07385365A Study of Postoperative Regional Nodal Radiotherapy in Intermediate-risk Breast Cancer
NCT01024712Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT07686796Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial
NCT07200947A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer.
NCT06591078Evaluation of Clinical Efficacy of Acupuncture in Improving Immune Response in Patients With Cervical Cancer
NCT04821843Neoadjuvant Treatment Modalities in Esophageal Cancer
NCT01492543Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer
NCT03955367Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
NCT05135364HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure
NCT07438847177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
NCT06993506Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
NCT04500704Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLC
NCT07684508Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer
NCT04528225A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer
NCT01238562Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients
NCT07440888The Factors Influencing the Success of Redo Surgery and Anal Function for Anastomosis Failure or Local Tumor Recurrence
NCT06215885Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules
NCT05352646NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
NCT07657494Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive Lymphoma: A Multicenter Study
NCT07204041Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCH
NCT07409766A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors
NCT03189277A Hospital Based Survey on Lung Cancer Related-pain in Northern China
NCT06861777Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC
NCT05028439RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma
NCT06048146A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis
NCT04339660Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia